Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Critical Nutrition Labs is a biotechnology company specializing in precision nutrition for critically ill patients in the intensive care unit (ICU). The company utilizes a proprietary platform that integrates metabolomics and machine learning to tailor nutritional therapy to the specific metabolic needs of individual patients. By analyzing real-time metabolic data, Critical Nutrition Labs seeks to transition medical nutrition from a generic approach to a targeted therapeutic modality that improves recovery rates and reduces ICU-acquired weakness. Their technology is designed to provide clinicians with actionable insights to optimize protein and energy delivery during the acute phase of illness. The company is currently advancing its data-driven nutritional interventions through clinical research and pilot programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Critical Nutrition Labs.